Industry
Insurance for Biotech & Life Sciences.
Biotech and life sciences companies face a risk profile shaped by long development timelines, significant capital deployed before revenue, and the regulatory complexity of FDA oversight. Clinical trial liability, product liability for approved therapies, intellectual property defense in a patent-intensive industry, and D&O exposure from investor disputes over trial outcomes all require specialized insurance structures.
Insurance Programs for Biotech and Life Sciences Companies
Biotech and life sciences companies face a risk profile shaped by long development timelines, significant capital deployed before revenue, and the regulatory complexity of FDA oversight. Clinical trial liability, product liability for approved therapies, intellectual property defense in a patent-intensive industry, and D&O exposure from investor disputes over trial outcomes all require specialized insurance structures.
How OnePark Risk Helps
OnePark Risk works with life sciences markets to place programs for clinical-stage biotechs, diagnostics companies, medical device manufacturers, and life sciences software platforms. We structure Clinical Trial Liability to cover research participants, coordinate Product Liability with regulatory approval milestones, and build D&O programs that account for the concentrated investor scrutiny that follows binary trial data readouts.
Biotech and Life Sciences Insurance Priorities
- Clinical Trial Liability protecting research participants and sponsors
- Product Liability for approved therapeutics and medical devices
- IP defense in a heavily litigated patent environment
- D&O coverage for investor disputes around trial outcomes
- Regulatory defense for FDA enforcement actions
- Cyber Liability for research data and HIPAA-governed trial information